Physician profile
Joy Clore
NPI 1659340867
$1,445.68
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $186 · 2021: $389 · 2022: $409 · 2023: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $389.05 | 2019-2022 | |
| Coopersurgical, INC. | $211.12 | 2021 | |
| Astellas Pharma US INC | $151.43 | 2022-2023 | Veozah |
| Pfizer INC. | $131.67 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.91 | 2019-2023 | |
| Therapeuticsmd, INC. | $74.54 | 2021-2022 | |
| Organon LLC | $52.53 | 2021-2022 | |
| Agile Therapeutics, INC. | $47.98 | 2021-2023 | Twirla |
| Allergan, INC. | $36.24 | 2019 | |
| Merck Sharp & Dohme LLC | $34.83 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $32.17 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $28.68 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $27.58 | 2019-2020 | |
| Medtronic, INC. | $25.37 | 2023 | Truclear |
| Novo Nordisk INC | $24.77 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $18.79 | 2021 | |
| Evofem Biosciences, INC. | $16.64 | 2021 | |
| Avion Pharmaceuticals | $15.01 | 2021 | |
| Urovant Sciences INC | $13.91 | 2021 | |
| Amgen INC. | $11.90 | 2019 | |
| Mayne Pharma Commercial LLC | $5.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Clore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.